Clinical Characteristics and Outcomes of Tympanomastoid Paragangliomas: A Report from Slovenia
Open Access
Abstract
(1) Background: Head and neck paragangliomas are neuroendocrine tumors that typically originate from the parasympathetic nervous system and are predominantly non-secretory. Their clinical manifestations result from their mass effect on the surrounding tissues. The approach to treating these tumors depends on factors such as their location, size, impact on adjacent structures, and the patient’s overall health and preferences. (2) Methods: A retrospective analysis of the management of temporal bone paraganglioma classes A and B (according to the modified Fisch classification) was performed at the University Medical Centre, Ljubljana, between 2011 and 2023. (3) Results: We analyzed 23 cases, 19 of which underwent surgery; complete tumor removal was achieved in 18 of them. Four patients were irradiated due to tumor progression to class C. Three of these four patients initially refused surgery and were treated with radiotherapy (RT) 7, 13, and 18 years after diagnosis. In the fourth patient, complete surgical resection was not achieved and she was treated with RT four years after surgery, due to the growth of the tumor to class C. The average follow-up time from diagnosis was 8.9 years (median 6 years; range 1–26 years). (4) Conclusions: The surgical treatment of patients with class A and B paragangliomas is effective and safe. In cases where surgery is refused but the tumor continues to grow to class C, RT is an alternative and efficient method of controlling tumor growth.Keywords
Funding Information
- the University Medical Centre, Ljubljana grant for Tertiary Research Projects (20240278, P3-0307)
- Slovenian Research and Innovation Agency (ARIS) (20240278, P3-0307)
This publication has 32 references indexed in Scilit:
- Overview of the 2022 WHO Classification of Paragangliomas and PheochromocytomasEndocrine Pathology, 2022
- Contemporary management of paragangliomas of the head and neckLaryngoscope Investigative Otolaryngology, 2021
- Feasibility of a wait-and-scan period as initial management strategy for head and neck paragangliomaHead & Neck, 2017
- Jugulotympanic paragangliomas in southern Finland: a 40-year experience suggests individualized surgical managementEuropean Archives of Oto-Rhino-Laryngology, 2016
- Strategies and long‐term outcomes in the surgical management of tympanojugular paragangliomasHead & Neck, 2015
- SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T)Laboratory Investigation, 2015
- Glomus Tympanicum TumorsOtolaryngologic Clinics of North America, 2015
- Middle ear and mastoid glomus tumors (glomus tympanicum): An algorithm for the surgical managementAuris Nasus Larynx, 2010
- An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysisThe Lancet Oncology, 2009
- Distinct Clinical Features of Paraganglioma Syndromes Associated With SDHB and SDHD Gene MutationsJAMA, 2004